Home/Filings/3/0001209191-18-052231
3//SEC Filing

Sofinnova Venture Partners IX, L.P. 3

Accession 0001209191-18-052231

CIK 0001724344other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 8:50 PM ET

Size

12.1 KB

Accession

0001209191-18-052231

Insider Transaction Report

Form 3
Period: 2018-09-25
Holdings
  • Series B-1 Tranche A Convertible

    Common Stock (7,446,904 underlying)
  • Series B-1 Tranche B Convertible

    Common Stock (9,502,249 underlying)
Holdings
  • Series B-1 Tranche B Convertible

    Common Stock (9,502,249 underlying)
  • Series B-1 Tranche A Convertible

    Common Stock (7,446,904 underlying)
Holdings
  • Series B-1 Tranche B Convertible

    Common Stock (9,502,249 underlying)
  • Series B-1 Tranche A Convertible

    Common Stock (7,446,904 underlying)
HEALY JAMES
10% Owner
Holdings
  • Series B-1 Tranche B Convertible

    Common Stock (9,502,249 underlying)
  • Series B-1 Tranche A Convertible

    Common Stock (7,446,904 underlying)
Mehra Anand
10% Owner
Holdings
  • Series B-1 Tranche A Convertible

    Common Stock (7,446,904 underlying)
  • Series B-1 Tranche B Convertible

    Common Stock (9,502,249 underlying)
Footnotes (2)
  • [F1]Each share of Series B-1 Tranche A Convertible Preferred Stock and Series B-1 Tranche B Convertible Preferred Stock is convertible at any time, at the option of the holder, into Common Stock, on a 20.728-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering.
  • [F2]The reportable shares are held of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Sofinnova Management IX, L.L.C. ("SM IX") is the general partner of SVP IX. The individual managing members of SM IX are Michael Powell, James Healy and Anand Mehra, and they may be deemed to share voting and dispositive power over the shares held by SVP IX. Such persons and entities disclaim beneficial ownership over the shares held by SVP IX except to the extent of any pecuniary interest therein.

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001612133

Filing Metadata

Form type
3
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 8:50 PM ET
Size
12.1 KB